Oman vs Tajikistan: HIV-positive TB patients on ART (antiretroviral therapy)
Oman
100.0%
in 2024
Tajikistan
100.0%
in 2024
Oman rank
1st
Tajikistan rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Oman
- Tajikistan
How they compare
Oman currently reports 100.0% against 100.0% in Tajikistan, a difference of 0.0%.
The two have swapped places 5 times across 17 shared years of data; in 2007 it was Oman ahead.
Oman ranks 1st and Tajikistan ranks 1st of 144 countries.
Across the 3 decades both report, Oman averaged higher in 2 and Tajikistan in 1.
Head to head by decade
| Decade | Oman | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 36.0% | 64.0% | Oman |
| 2010s | 92.3% | 74.2% | 18.1% | Oman |
| 2020s | 91.4% | 97.8% | 6.4% | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Oman or Tajikistan?
- Oman, at 100.0% against 100.0% in Tajikistan as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Oman and Tajikistan?
- 0.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Tajikistan?
- 17 years are reported by both, from 2007 to 2024.
- How do Oman and Tajikistan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Oman ranks 1st and Tajikistan ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.